{
    "organizations": [],
    "uuid": "6764b1d4871c9c1fd34fd0a0bc9854f66a475029",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-loxo-oncology-reports-qtrly-loss-p/brief-loxo-oncology-reports-qtrly-loss-per-share-of-0-12-idUSASC0A0DE",
    "ord_in_thread": 0,
    "title": "BRIEF-Loxo Oncology Reports Qtrly Loss Per Share Of $0.12",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 8 (Reuters) - Loxo Oncology Inc:\n* LOXO ONCOLOGY REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS\n* LOXO ONCOLOGY - AS OF MARCH 31, 2018, CO HAD AGGREGATE CASH, CASH EQUIVALENTS AND INVESTMENTS OF $735.6 MILLION, COMPARED TO $626.2 MILLION AS OF DEC 31, 2017\n* LOXO ONCOLOGY INC - QTRLY LOSS PER SHARE $0.12\n* LOXO ONCOLOGY INC - QTRLY ADJUSTED LOSS PER SHARE $1.22 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-08T18:55:00.000+03:00",
    "crawled": "2018-05-09T12:31:32.004+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "loxo",
        "oncology",
        "inc",
        "loxo",
        "oncology",
        "report",
        "first",
        "quarter",
        "financial",
        "result",
        "loxo",
        "oncology",
        "march",
        "co",
        "aggregate",
        "cash",
        "cash",
        "equivalent",
        "investment",
        "million",
        "compared",
        "million",
        "dec",
        "loxo",
        "oncology",
        "inc",
        "qtrly",
        "loss",
        "per",
        "share",
        "loxo",
        "oncology",
        "inc",
        "qtrly",
        "adjusted",
        "loss",
        "per",
        "share",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}